Discover the latest in lymphoma diagnosis and treatment with Dr. Rodondo, from chemotherapy to emerging targeted therapies.
Join Our Webinar: Advances in Lymphoma Treatment with Dr. Alba Rodondo
Massive Bio invites you to an insightful webinar on Lymphoma, featuring Dr. Alba Rodondo, a leading hematologist and head of department in Extremadura, Spain.
Dr. Rodondo will discuss the latest advancements in lymphoma diagnosis and treatment, including chemotherapy, immunotherapy, radiation therapy, and emerging targeted therapies. She will also highlight clinical trials, CAR-T cell therapy, and the importance of personalized treatment plans to improve patient outcomes.
What to Expect:
- Understanding Lymphoma: Overview of Hodgkin and Non-Hodgkin lymphoma
- Standard Treatment Options: Chemotherapy, radiation therapy, and targeted therapies
- Indolent vs. Aggressive Lymphoma: How treatment strategies differ
- Managing Side Effects: Strategies to minimize treatment-related toxicity
- Breakthroughs in Immunotherapy: The role of monoclonal antibodies and targeted therapies
- CAR-T Cell Therapy: Current approvals and ongoing research
- Clinical Trials: How patients can access innovative treatment options
- Multidisciplinary Care: The role of collaboration in personalized treatment plans
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to gain expert insights and explore evolving lymphoma treatments.
Meet the Speakers
Dr. Alba Maria Redondo Guijo
Hematologist
Fiona Evans
Director, Patient Relations
Discover Your Options, Today
Interested in learning more about how clinical trials could be part of your cancer care strategy?
Let’s explore opportunities for your best options, together.
Discover your personalized cancer clinical trials options
Discover your personalized cancer clinical trials options
Join Our Webinar: Advances in Lymphoma Treatment with Dr. Alba Rodondo
Massive Bio invites you to an insightful webinar on Lymphoma, featuring Dr. Alba Rodondo, a leading hematologist and head of department in Extremadura, Spain.
Dr. Rodondo will discuss the latest advancements in lymphoma diagnosis and treatment, including chemotherapy, immunotherapy, radiation therapy, and emerging targeted therapies. She will also highlight clinical trials, CAR-T cell therapy, and the importance of personalized treatment plans to improve patient outcomes.
What to Expect:
- Understanding Lymphoma: Overview of Hodgkin and Non-Hodgkin lymphoma
- Standard Treatment Options: Chemotherapy, radiation therapy, and targeted therapies
- Indolent vs. Aggressive Lymphoma: How treatment strategies differ
- Managing Side Effects: Strategies to minimize treatment-related toxicity
- Breakthroughs in Immunotherapy: The role of monoclonal antibodies and targeted therapies
- CAR-T Cell Therapy: Current approvals and ongoing research
- Clinical Trials: How patients can access innovative treatment options
- Multidisciplinary Care: The role of collaboration in personalized treatment plans
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to gain expert insights and explore evolving lymphoma treatments.
Meet the Speakers
Dr. Alba Maria Redondo Guijo
Hematologist
Fiona Evans
Director, Patient Relations